IsoPlexis Investor Relations Material
Latest events
Status Update
IsoPlexis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IsoPlexis Corporation
Access all reports
IsoPlexis Corporation is a life sciences company that develops single-cell analysis solutions to advance precision medicine and immunology research. The company’s technology platform allows researchers to analyze the functional proteomics of individual cells, providing insights into immune system responses and disease progression. The company is headquartered in Branford, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ISO
Country
🇺🇸 United States